Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Identify the mix that offers broader exposure for retirement by comparing Sp500 and total market allocations and adjusting for risk.
28,595 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Huntington & Ellis launches Smart by h&e, an in-house AI assistant designed to streamline deals, draft communications...
Dogecoin strengthens its footing as ETF inflows stay in positive territory through May, with key resistance near $0.1...
Investors confront a cooling AI rally as Rambus faces growth deceleration and valuation pressures, signaling a potent...
Major U.S. banks are moving to launch a tokenized deposit network in 2027, aiming to bridge traditional payments with...
ADA neared a multi-year trough as markets digested a broad crypto selloff. Analysts warn gains may come, but a cardan...
Former Prime Minister Justin Trudeau has purchased a Montreal mansion for $3.1 million, a move that has investors wat...
SpaceX signals a potential $75 billion IPO, elevating CFO Bret Johnsen to the center of a new phase focused on govern...
SpaceX briefly cleared the $200 level before retreating, sparking renewed debate over whether the stock is a standalo...
XRP remains unable to break above $1.30, trading around the mid-$1.1s as traders weigh whether a reclaim $1.30? is wi...
SpaceX's massive debt offering sent a chill through space-focused equities as Virgin Galactic and Rocket Lab swayed o...
President Trump dismissed the 21st Century ROAD to Housing Act as a yawn and canceled a signing ceremony, redirecting...